These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 28324091

  • 21. Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.
    Hernandez I, Zhang Y, Brooks MM, Chin PK, Saba S.
    Stroke; 2017 Jan; 48(1):159-166. PubMed ID: 27909200
    [Abstract] [Full Text] [Related]

  • 22. Factors influencing dabigatran or warfarin medication persistence in patients with nonvalvular atrial fibrillation.
    Annavarapu S, Gandhi PK, Li Y, Arora P, Moretz C, Wang C, Sander SD, Andrews GA.
    J Comp Eff Res; 2018 Jul; 7(7):685-691. PubMed ID: 29808717
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of Fracture Risk Among Patients With Type 2 Diabetes and Nonvalvular Atrial Fibrillation Receiving Different Oral Anticoagulants.
    Lui DTW, Ho Man Tang E, Au ICH, Wu T, Lee CH, Wong CK, Cheung CYY, Fong CHY, Chow WS, Woo YC, Tan KCB, Lam KSL, Wong CKH.
    Diabetes Care; 2022 Nov 01; 45(11):2620-2627. PubMed ID: 36126158
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study.
    Lauffenburger JC, Farley JF, Gehi AK, Rhoney DH, Brookhart MA, Fang G.
    J Am Heart Assoc; 2015 Apr 10; 4(4):. PubMed ID: 25862791
    [Abstract] [Full Text] [Related]

  • 25. Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation.
    Seeger JD, Bykov K, Bartels DB, Huybrechts K, Zint K, Schneeweiss S.
    Thromb Haemost; 2015 Nov 25; 114(6):1277-89. PubMed ID: 26446507
    [Abstract] [Full Text] [Related]

  • 26. 'Real-world' haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand.
    Nishtala PS, Gnjidic D, Jamieson HA, Hanger HC, Kaluarachchi C, Hilmer SN.
    Int J Cardiol; 2016 Jan 15; 203():746-52. PubMed ID: 26590888
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB, Skjøth F, Søgaard M, Kjældgaard JN, Lip GY, Larsen TB.
    BMJ; 2017 Feb 10; 356():j510. PubMed ID: 28188243
    [Abstract] [Full Text] [Related]

  • 28. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
    Ali A, Bailey C, Abdelhafiz AH.
    Age Ageing; 2012 Sep 10; 41(5):681-4. PubMed ID: 22378612
    [Abstract] [Full Text] [Related]

  • 29. Hospital Admissions, Costs, and 30-Day Readmissions Among Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran Etexilate or Warfarin.
    Fonseca E, Sander SD, Hess GP, Ghosh S.
    J Manag Care Spec Pharm; 2015 Nov 10; 21(11):1039-53. PubMed ID: 26521116
    [Abstract] [Full Text] [Related]

  • 30. Sequential Monitoring of the Comparative Effectiveness and Safety of Dabigatran in Routine Care.
    Schneeweiss S, Gopalakrishnan C, Bartels DB, Franklin JM, Zint K, Kulldorff M, Huybrechts KF.
    Circ Cardiovasc Qual Outcomes; 2019 Feb 10; 12(2):e005173. PubMed ID: 30764655
    [Abstract] [Full Text] [Related]

  • 31. Health Care Costs and Utilization of Dabigatran Compared With Warfarin for Secondary Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation: A Retrospective Population Study.
    Chi NF, Wang Y, Chien LN, Chien SC, Ko Y.
    Med Care; 2018 May 10; 56(5):410-415. PubMed ID: 29578954
    [Abstract] [Full Text] [Related]

  • 32. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA.
    Circulation; 2015 Jan 13; 131(2):157-64. PubMed ID: 25359164
    [Abstract] [Full Text] [Related]

  • 33. Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan.
    Chan YH, Chao TF, Chen SW, Lee HF, Chen WM, Li PR, Yeh YH, Kuo CT, See LC, Lip GYH.
    JAMA Netw Open; 2022 Nov 01; 5(11):e2243307. PubMed ID: 36413365
    [Abstract] [Full Text] [Related]

  • 34. Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation.
    Chan PH, Huang D, Hai JJ, Li WH, Yin LX, Chan EW, Wong IC, Lau CP, Chiang CE, Zhu J, Tse HF, Siu CW.
    Heart Rhythm; 2016 Feb 01; 13(2):366-73. PubMed ID: 26392326
    [Abstract] [Full Text] [Related]

  • 35. Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.
    Laliberté F, Cloutier M, Crivera C, Nelson WW, Olson WH, Schein J, Vanderpoel J, Germain G, Lefebvre P.
    Clin Ther; 2015 Mar 01; 37(3):554-62. PubMed ID: 25749196
    [Abstract] [Full Text] [Related]

  • 36. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
    Chan EW, Lau WC, Leung WK, Mok MT, He Y, Tong TS, Wong IC.
    Gastroenterology; 2015 Sep 01; 149(3):586-95.e3. PubMed ID: 25960019
    [Abstract] [Full Text] [Related]

  • 37. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.
    Ann Intern Med; 2011 Jan 04; 154(1):1-11. PubMed ID: 21041570
    [Abstract] [Full Text] [Related]

  • 38. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
    Douketis JD, Healey JS, Brueckmann M, Eikelboom JW, Ezekowitz MD, Fraessdorf M, Noack H, Oldgren J, Reilly P, Spyropoulos AC, Wallentin L, Connolly SJ.
    Thromb Haemost; 2015 Mar 04; 113(3):625-32. PubMed ID: 25472710
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Kamel H, Johnston SC, Easton JD, Kim AS.
    Stroke; 2012 Mar 04; 43(3):881-3. PubMed ID: 22308255
    [Abstract] [Full Text] [Related]

  • 40. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2.
    Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF.
    Arch Intern Med; 2006 Jan 23; 166(2):241-6. PubMed ID: 16432096
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.